Report Tools

Johnson & Johnson - SWOT, Strategy and Corporate Finance Report

Published: June 2013 · Publisher: MarketLine
Johnson & Johnson - SWOT, Strategy and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings, etc.
Report Type Company Profiles
Language English
Format Electronic (PDF)
Pages84
Frequency Updated Annually
Availability Will be emailed within 1 business day
Reference No. 0109-6593
Price € 129,00
Options
  • Description
  • Table of Contents
  • Ask a Question
Johnson & Johnson - SWOT, Strategy and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings, detailed financials, and corporate actions, providing a 360˚ view of the company.

Features:

- Detailed information on Johnson & Johnson required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Johnson & Johnson in the form of a SWOT analysis
- An in-depth view of the business model of Johnson & Johnson including a breakdown and examination of key business segments
- Five-year financial information and charts, including balance sheet, income statement, cash flows, market capitalization and multiples, and key ratios for Johnson & Johnson
- Intelligence on Johnson & Johnsonnv’s mergers and acquisitions (M&A), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Johnson & Johnson, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Highlights:

Johnson & Johnson (J&J or 'the company') is the world's leading provider of diverse health products. It is engaged in the research, development, manufacture and sale of consumer health care products, pharmaceuticals, medical devices and diagnostics. The company has more than 275 operating companies. It operates in the Americas, Europe, Asia Pacific and Africa. The company is headquartered in New Brunswick, New Jersey, and employed about 127,600 people as of December 30, 2012. The company recorded revenues of $67,224 million during the financial year ended December 2012 (FY2012), an increase of 3.4% over FY2011. The operating profit of the company was $13,243.1 million* in FY2012, a decrease of 19.8% over FY2011. The net profit was $10,853 million in FY2012, an increase of 12.2% over FY2011. *Earnings before interest and taxes.

Reasons to Purchase:

- Gain understanding of Johnson & Johnson and the factors that influence its strategies
- Track strategic initiatives of the company and latest corporate news and actions
- Assess Johnson & Johnson as a prospective partner, vendor or supplier
- Support sales activities by understanding your customers' businesses better
- Stay up to date on Johnson & Johnson’s business structure, strategy and prospects

Copyright © FriedlNet. You may share using our tools Please don't cut content from FriedlNet and redistribute by email or post to the web.
Company Snapshot
Johnson & Johnson: Company Overview
Johnson & Johnson: Overview and Key Facts
Johnson & Johnson: Overview
Johnson & Johnson: Key Facts
Johnson & Johnson: Key Employees
Johnson & Johnson: Key Employee Biographies
Johnson & Johnson: Major Products and Services
Johnson & Johnson: Company History
Johnson & Johnson: Management Statement
Johnson & Johnson: Locations and Subsidiaries
Johnson & Johnson: Key Competitors
Johnson & Johnson: Company Analysis
Johnson & Johnson: Business Description
Johnson & Johnson: SWOT Analysis
Johnson & Johnson: SWOT Overview
Johnson & Johnson: Strengths
Johnson & Johnson: Weaknesses
Johnson & Johnson: Opportunities
Johnson & Johnson: Threats
Johnson & Johnson: Financial Analysis
Johnson & Johnson: Financial Overview
Johnson & Johnson: Five Year Company Financials
Johnson & Johnson: Key Income Statement Data
Johnson & Johnson: Key Balance Sheet Data
Johnson & Johnson: Key Cash Flow Data
Johnson & Johnson: Key Market Data
Johnson & Johnson: Valuation Ratios
Johnson & Johnson: Profitability Ratios
Johnson & Johnson: Management Efficiency Ratios
Johnson & Johnson: Financial Strength Ratios
Johnson & Johnson: Operational Efficiency Ratios
Johnson & Johnson: Others
Johnson & Johnson: Corporate Financial Deals Activity
Johnson & Johnson: Financial Deals Overview
Johnson & Johnson: Targets and Partners
Johnson & Johnson: Top Deals 2009 - 2013YTD*
Johnson & Johnson: Advisors
Johnson & Johnson: Top Legal Advisors
Johnson & Johnson: Top Financial Advisors
Johnson & Johnson: Mergers and Acquisitions
Johnson & Johnson: Corporate Venturing
Johnson & Johnson: Partnership
Johnson & Johnson: Divestments
Johnson & Johnson: Recent Developments
Johnson & Johnson: News and Events Summary
Johnson & Johnson: Business Expansion
Johnson & Johnson: Contracts
Johnson & Johnson: Corporate Social Responsibility
Johnson & Johnson: Financial Deals
Johnson & Johnson: Financial Performance
Johnson & Johnson: Red Flags/DistressSignals
Johnson & Johnson: Regulatory and Legal Events
Johnson & Johnson: Research & Development
Johnson & Johnson: Strategy and Operations
Appendix
Contact Us
Methodology
Definitions


List of Tables

Table 1: Johnson & Johnson: Key Facts
Table 2: Johnson & Johnson: Key Employees
Table 4: Johnson & Johnson: Key Competitors
Table 5: Johnson & Johnson: Key Income Statement Data
Table 6: Johnson & Johnson: Key Balance Sheet Data
Table 7: Johnson & Johnson: Key Cash Flow Data
Table 8: Johnson & Johnson: Key Market Data
Table 9: Johnson & Johnson: Key Growth Ratios
Table 10: Johnson & Johnson: Valuation Ratios
Table 11: Johnson & Johnson: Profitability Ratios
Table 12: Johnson & Johnson: Management Efficiency Ratios
Table 13: Johnson & Johnson: Financial Strength Ratios
Table 14: Johnson & Johnson: Operational Efficiency Ratios
Table 15: Johnson & Johnson: Others
Table 16: Johnson & Johnson: Deal Activity by Deal Type - Volume (TTM*)
Table 17: Johnson & Johnson: M&A Activity by Geography (TTM*)
Table 18: Johnson & Johnson: Deal Activity by Deal Type - Volume (2009 - YTD*2013)
Table 19: Johnson & Johnson: M&A Average Deal Size - Value (US$m)
Table 20: Johnson & Johnson: Targets and Partners
Table 21: Johnson & Johnson: Top Deals 2009 - 2013YTD*
Table 22: Johnson & Johnson: Legal Advisor Ranking by Value (US$m)
Table 23: Johnson & Johnson: Financial Advisor Ranking by Value (US$m)
Table 24: Johnson & Johnson: M&A Volume and Value Trend (2009 - YTD*2013)
Table 25: Johnson & Johnson: M&A Activity by Geography (2009 - YTD*2013)
Table 26: Johnson & Johnson: Corporate Venturing Volume and Value Trend (2009 - YTD*2013)
Table 27: Johnson & Johnson: Corporate Venturing by Geography (2009 - YTD*2013)
Table 28: Johnson & Johnson: Partnership Volume and Value Trend (2009 - YTD*2013)
Table 29: Johnson & Johnson: Partnership Trend by Deal Type (2009 - YTD*2013)
Table 30: Johnson & Johnson: Divestments Volume and Value Trend (2009 - YTD*2013)
Table 31: Johnson & Johnson: Divestments by Geography (2009 - YTD*2013)
Table 32: Johnson & Johnson: News and Events Summary
Table 33: Johnson & Johnson: Business Expansion
Table 34: Johnson & Johnson: Contracts
Table 35: Johnson & Johnson: Corporate Social Responsibility
Table 36: Johnson & Johnson: Financial Deals
Table 37: Johnson & Johnson: Financial Performance
Table 38: Johnson & Johnson: Red Flags/DistressSignals
Table 39: Johnson & Johnson: Regulatory and Legal Events
Table 40: Johnson & Johnson: Research & Development
Table 41: Johnson & Johnson: Strategy and Operations

List of Figures

Figure 1: Johnson & Johnson: Revenue to Net Income (2007-2011)
Figure 2: Johnson & Johnson: Revenue/Employee to Net Income/Employee (2007-2011)
Figure 3: Johnson & Johnson: Current Assets to Current Liabilities (2007-2011)
Figure 4: Johnson & Johnson: Assets, Liabilities to Total Equity (2007-2011)
Figure 5: Johnson & Johnson: Free Cash Flow to Cash from Operating Activities (2007-2011)
Figure 6: Johnson & Johnson: Net Change in Cash (2007-2011)
Figure 7: Johnson & Johnson: Market Capitalization to Year-end Share Price (2007-2011)
Figure 8: Johnson & Johnson: Enterprise Value (2007-2011)
Figure 9: Johnson & Johnson: Deal Activity by Deal Type - Volume (TTM*)
Figure 10: Johnson & Johnson: M&A Activity by Geography (TTM*)
Figure 11: Johnson & Johnson: Deal Activity by Deal Type - Volume (2009 - YTD*2013)
Figure 12: Johnson & Johnson: M&A Average Deal Size - Value (US$m)
Figure 13: Johnson & Johnson: M&A Volume and Value Trend (2009 - YTD*2013)
Figure 14: Johnson & Johnson: M&A Activity by Geography (2009 - YTD*2013)
Figure 15: Johnson & Johnson: Corporate Venturing Volume and Value Trend (2009 - YTD*2013)
Figure 16: Johnson & Johnson: Corporate Venturing by Geography (2009 - YTD*2013)
Figure 17: Johnson & Johnson: Partnership Volume and Value Trend (2009 - YTD*2013)
Figure 18: Johnson & Johnson: Partnership Trend by Deal Type (2009 - YTD*2013)
Figure 19: Johnson & Johnson: Divestments Volume and Value Trend (2009 - YTD*2013)
Figure 20: Johnson & Johnson: Divestments by Geography (2009 - YTD*2013)
Copyright © FriedlNet. You may share using our tools Please don't cut content from FriedlNet and redistribute by email or post to the web.